ABSTRACT
The global environmental concern surrounding microplastic (MP) pollution has raised alarms due to its potential health risks to animals, plants, and humans. Because of the complex structure and composition of microplastics (MPs), the detection methods are limited, resulting in restricted detection accuracy. Surface enhancement of Raman spectroscopy (SERS), a spectral technique, offers several advantages, such as high resolution and low detection limit. It has the potential to be extensively employed for sensitive detection and high-resolution imaging of microplastics. We have summarized the research conducted in recent years on the detection of microplastics using Raman and SERS. Here, we have reviewed qualitative and quantitative analyses of microplastics and their derivatives, as well as the latest progress, challenges, and potential applications.
Subject(s)
Microplastics , Spectrum Analysis, Raman , Animals , Humans , Spectrum Analysis, Raman/methods , Plastics/analysis , Environmental Monitoring , Environmental Pollution/analysisABSTRACT
The objective of this study was to predict the droplet size and the spraying angle during the process of binder atomization in pharmaceutical fluidized bed granulation using an empirical model. The effects of the binder viscosity, the atomization pressure, and the spray rate on the droplet size and the spraying angle were investigated using a response surface central composite design and analysis of variance. Prediction models for droplet size and spraying angle were then established using stepwise regression analysis and were validated by comparing the measured and predicted values. The results showed that the droplet size model and the spraying angle model were well established, with an R2 of 0.93 (p < 0.0001) and a root mean square error (RMSE) of 10.10, and an R2 of 0.82 (p < 0.0001) and an RMSE of 3.69, respectively. The error between the measured and predicted values of the droplet size and the spraying angle were less than 10%, indicating that the established models were accurate. The results of the present study were significant in predicting the droplet size and spraying angle in the process of pharmaceutical fluidized bed granulation.
Subject(s)
Empirical Research , Hypromellose Derivatives/chemical synthesis , Particle Size , Povidone/chemical synthesis , Technology, Pharmaceutical/methods , Forecasting , ViscosityABSTRACT
As research progresses, the intricate metabolic connections between depression and tryptophan, as well as kynurenine (KYN), have become increasingly evident. In studies investigating the relationship between KYN and depression, the conclusions reached thus far have been inconsistent. Therefore, we propose employing a two-sample mendelian randomization (MR) approach to further elucidate the relationship between KYN and depression. We utilized extensive data from large-scale genome-wide association studies to identify single nucleotide polymorphisms that act as instrumental variables for kynurenine and depression in European ancestry populations, ensuring compliance with MR assumptions. We employed five MR algorithms, namely, weighted median, MR-Egger, inverse variance weighted (IVW), simple mode, and weighted mode, with IVW as the primary analysis method. Sensitivity tests were conducted using Cochran's Q test, MR-Egger intercept test, MR Pleiotropy Residual Sum and Outlier, and Leave-one-out analysis.The IVW analysis revealed that each standard deviation increase in kynurenine corresponded to a 1.4-fold increase in the risk of depression (OR = 1.351, 95% CI 1.110-1.645, P = 0.003). The direction of the effect size (positive or negative) was consistent with the findings from the other four algorithms. Sensitivity tests indicated no heterogeneity or horizontal pleiotropy among the instrumental variables. Elevated levels of kynurenine have a causal relationship with an increased risk of developing depression.
Subject(s)
Depression , Kynurenine , Depression/genetics , Genome-Wide Association Study , Mendelian Randomization Analysis , TryptophanABSTRACT
Arthritis is a general term for various types of inflammatory joint diseases. The most common clinical conditions are mainly represented by rheumatoid arthritis and osteoarthritis, which affect more than 4% of people worldwide and seriously limit their mobility. Arthritis medication generally requires long-term application, while conventional administrations by oral delivery or injections may cause gastrointestinal side effects and are inconvenient for patients during long-term application. Emerging microneedle (MN) technology in recent years has created new avenues of transdermal delivery for arthritis drugs due to its advantages of painless skin perforation and efficient local delivery. This review summarizes various types of arthritis and current therapeutic agents. The current development of MNs in the delivery of arthritis drugs is highlighted, demonstrating their capabilities in achieving different drug release profiles through different self-enhancement methods or the incorporation of nanocarriers. Furthermore, the challenges of translating MNs from laboratory studies to the clinical practice and the marketplace are discussed. This promising technology provides a new approach to the current drug delivery paradigm in treating arthritis in transdermal delivery.
ABSTRACT
In this article, the effect of the chitosan molecular weight (MW) on the characteristics of methotrexate (MTX)-encapsulated non-cross-linked chitosan microspheres was studied. Microspheres composed of low-molecular-weight (LMW, 40,000 Da), medium-molecular-weight (MMW, 480,000 Da) and high-molecular-weight (HMW, 850,000 Da) chitosan with the same degree of deacetylation (96%) were obtained by a simple spray-drying method. The MW of chitosan had a noticeable influence on the size distribution, encapsulation efficiency, micromeritic properties (angle of repose and bulk density), controlled release behavior, and mucoadhesive properties. The entrapment efficiencies were in the range of 90-99%. Spray-dried microspheres had a D(50) value of 3.3-4.9 microm, which was suitable for nasal insufflations. The microspheres with LMW chitosan have the best flowability and highest bulk density but were found to be poor in terms of adhesion and in controlling the release behavior of MTX. The MMW chitosan microspheres exhibited the strongest adhesion to the mucosal surface, and the angle of repose values were between 34 and 47 degrees. They could control the release rate by modifying the drug/polymer ratios. Microspheres with HMW chitosan exhibited a lower adhesion than MMW chitosan and a lower release rate of MTX. The physical state of MTX in the chitosan matrix was studied by differential scanning calorimetry, which indicated the presence of a solid dispersion of the amorphous drug in the chitosan matrix. Nasal ciliotoxity showed only minor cilia irritation due to the microspheres, and consequently, they are suitable for nasal drug delivery.
Subject(s)
Antimetabolites, Antineoplastic/administration & dosage , Chitosan/chemistry , Drug Carriers/chemistry , Methotrexate/administration & dosage , Adhesiveness , Administration, Intranasal , Animals , Antimetabolites, Antineoplastic/chemistry , Antimetabolites, Antineoplastic/toxicity , Anura , Calorimetry, Differential Scanning , Cilia/drug effects , Delayed-Action Preparations , Methotrexate/chemistry , Methotrexate/toxicity , Microspheres , Molecular Weight , Particle Size , Toxicity TestsABSTRACT
To improve the patient's compliance and enhance the stability of oily drugs in the gastric fluid, an enteric-soluble solid-state emulsion (ESE), was developed. The ESE was prepared by spreading liquid o/w-emulsions on a flat glass and drying at the oven maintained at 40 degrees C. Aerosil 200 was applied as solid carrier and emulsifier. And Eudragit L30D-55 was used as enteric coating material. The influence of various preparation parameters on the residual volatile oil and the release behavior was investigated. Droplet size distribution of the primary emulsions and the emulsion after reconstitution of zedoary turmeric oil (ZTO) ESE in the phosphate buffer were also measured. When ZTO ESE was immersed into phosphate buffer (pH 6.8), the stable emulsion was formed in 20min, but the release was obviously suppressed when it was exposed to the gastric fluid. It was concluded that preparation of enteric-soluble solid-state emulsion by the present method for oral oily drug was feasible.
Subject(s)
Curcuma , Emulsions/chemistry , Technology, Pharmaceutical/methods , Delayed-Action Preparations , Emulsifying Agents/chemistry , Methacrylates/chemistry , Oils, Volatile/chemistry , Particle Size , Plasticizers/chemistry , Polymers/chemistry , Silicon Dioxide/chemistryABSTRACT
Neuroactive steroids (NASs) have been shown to impact central nervous system (CNS) function through positive allosteric modulation of the GABA(A) receptor (GABA(A)-R). Herein we report the effects on the activity and pharmacokinetic properties of a series of nor-19 pregnanolone analogues bearing a heterocyclic substituent at C-21. These efforts resulted in the identification of SGE-516, a balanced synaptic/extrasynaptic GABA(A) receptor modulator, and SGE-872, a selective extrasynaptic GABA(A) receptor modulator. Both molecules possess excellent druglike properties, making them advanced leads for oral delivery of GABA(A) receptor modulators.